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ABSTRACT 
 Alcohol abuse is the fourth leading cause of preventable death in the United 
States (National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2016). Alcohol 
affects us on a molecular, biological, and even societal level.  Liver damage, cancer, and 
drunk driving accidents are only a few adverse consequences of alcohol abuse. Studies 
have also shown that alcohol abuse can damage the brain, in part by activating the central 
nervous system’s immune system, leading to inflammation and demyelination. This 
damage may lead to alcohol-related psychiatric disorders, motor impairment, and 
cognitive disabilities. Studies have also shown that females tend to exhibit more damage 
with less alcohol consumption than males, and that genetic background influences 
sensitivity to the drug. Thus, studying alcohol addiction at a biological level with special 
care for how sex and genetic background influence this phenomenon is key to 
understanding addiction and delivering effective treatment. In the present experiment, I 
examined the brain’s immune response to alcohol withdrawal by performing 
immunohistochemical analysis of microglial activation at two post-withdrawal time 
points in female C3H/HeJ inbred mice. In this experiment, alcohol dependence was 
induced using an ethanol-vapor exposure protocol shown previously in our lab to 
generate long-lasting impairment of spontaneous behavioral activity.   
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INTRODUCTION 
Alcohol use is prevalent in many cultures, and its use ranges from social 
gatherings to religious ceremonies. However, despite decades of stigmatism towards 
individuals suffering from alcohol dependence, the abuse of alcohol is still one of the 
leading causes of death in the U.S. and not only harms the abuser but their society as 
well. Alcohol abuse has been shown to cause or exacerbate certain neurological 
disorders, several types of cancers, road accidents, and other deleterious consequences 
(World Health Organization [WHO], 2014).  Currently, alcohol dependence is diagnosed 
as Alcohol Use Disorder (AUD), a medical condition detailed in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM 5). Alcohol abuse is therefore not merely a 
deviant behavior but a disease that needs treatment (NIAAA, “Alcohol Use Disorder”). 
AUD is best defined as an addiction where a person actively seeks and consumes alcohol 
excessively regardless of knowing the negative consequences of said actions. A person 
who suffers from an AUD may want to stop but will have extreme difficulty doing so 
(NIAAA, “Alcohol Use Disorder”), and are thus described as having “lost control” of 
their drinking. 
Brain Damage Associated with Ethanol Exposure 
Ethanol, the form of alcohol found in alcoholic beverages, is a small polar 
molecule consisting only of 2 carbons, 1 oxygen, and 6 hydrogens that easily transverses 
epithelial linings such as the gastrointestinal tissue (National Center for Biotechnology 
Information [NCBI], n.d). This pervasiveness causes alcohol to permeate throughout the 
body via the circulatory system.   
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Human and animal studies have shown that alcohol abuse impacts the liver, 
pancreas, heart, and central nervous system, sometimes causing permanent damage such 
as liver scarring and cardiomyopathy (NIAAA, “Alcohol’s Effects on the Body”). 
Though damage to any of these organs can be life-threatening, damage to the nervous 
system can cause psychological changes such as memory loss, motor impairment, mood 
disorder, addiction, and a change in personality.   
Alcohol abuse causes the brain to undergo changes ranging from a 
macrostructural to a molecular scale, including large lesions, neuronal degradation, 
dendritic spine morphological changes, and even altered neurotransmitter response (Gass, 
2012). Starting from the macrostructural changes, the brains of alcoholics in both animals 
and humans are smaller than their non-alcoholic counterparts. With imaging analyses 
such as magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI), studies 
have also shown that ventricular cavities are larger and myelin integrity is decreased in 
alcoholic models (Pfefferbaum, Rosenbloom, Rohlfing, & Sullivan, 2009; Zahr, et al., 
2010, “Brain Injury”). Within the brain, several nuclei, white matter fiber tracts, and 
other areas seem to be particularly susceptible to damage such as demyelination and a 
cessation of neurogenesis. These areas include the frontal lobe, corpus callosum, 
hypothalamus, and hippocampus (Pfefferbaum et al., 2009; & Crews & Nixon, 2008; He, 
Sullivan, Stankovic, Harper, Pfefferbaum, 2007; Chastain & Sarkar, 2014; Mayfield, 
Lewohl, Dodd, Herlihy, Liu, Harris, 2002). Each of these regions play an important role 
not limited to integrating the cerebral hemispheres together and/or other brain structures, 
memory formation, and behavior respectively. The frontal lobe in particular is associated 
with decision making, attention, and impulse inhibition. As a result of this damage, long-
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term human alcoholics are afflicted with impaired judgement, attention deficit, and lack 
of impulse control (Crews, 2008). Both alcoholic animals and humans also display 
learning and memory deficits, and depression and anxiety-like behaviors (Yang et al., 
2014; Pascual, Balino, Aragon, Guerri, 2015; Crews, 2008; and Pfefferbaum et al., 2009). 
Demyelination/Neuronal Level 
On a neuronal level, demyelination may not always kill neurons, but can 
nevertheless have disastrous effects on brain function. Myelin is a whitish fatty substance 
produced by Schwann cells and oligondendrocytes. These specialized cells create sheaths 
along neuron axons to increase conduction speed. Affecting the speed and 
communication of neurons can greatly interfere with their function. Demyelination also 
occurs in multiple sclerosis, HIV, and central pontine myelinolysis (Love, 2006).   
Through the use of quantitative fiber tracking quantified from diffusion tensor 
imaging (DTI), Pfefferbaum and his lab saw that neuron fiber integrity was degraded in 
human chronic alcohol users, especially in anterior (internal and external capsules, frontal 
forceps, and fornix) and superior (superior cingulate) association fibers. The extent of 
damage in these areas positively correlated with the years the participants used alcohol. 
Cognitive and motor tests such as balancing on one foot and completing digit symbol 
grids were also conducted in Pfefferbaum’s study. They found that myelin damage 
negatively correlated with test scores (Pfefferbaum et al., 2009). 
Immune Response & Microglia 
Although the exact mechanisms that cause myelin destruction and other forms of 
ethanol -created damage in the brain are yet to be known, several biochemical pathways 
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and immune responses have been found to become activated with alcohol abuse. Of 
special interest are microglia. Microglia are the primary immune system cell of the 
central nervous system and perform phagocytosis, release immune factors, and initiate 
apoptosis allowing damage, debris, and foreign invaders to be taken care of by the on-site 
microglia and other responding immune cells (Chastain, Sarkar, 2014). While resting, 
microglia are usually ramified, but upon activation will become amoeboid as they 
proliferate and perform their immune system duties. Activated microglia can be further 
identified by their cytokine phenotype. The M1 phenotype releases proinflammatory 
factors while the M2 phenotype releases anti-inflammatory factors (Chastain & Sarkar, 
2014). The role of the microglia is indispensable; however, studies have linked microglial 
activation to neuroinflammation and subsequent damage seen in alcoholics (Fernandez-
Lizarbe, Pascual, Guerri, 2009; Boyadjieva, Sarkar, 2013; Chastain, Sarkar, 2014; 
Pascual et al., 2015). 
Microglia are thought to afflict damage by overreacting to the ethanol exposure 
through 2 different pathways: oxidative stress from pro-inflammatory cytokines and 
neuroinflammation. Ethanol exposure alters the expression of certain genes and 
transcription factors important for protecting neurons. Ethanol increases nuclear factor 
κB (NF-κB) transcription which has roles in inflammatory and other immune responses. 
cAMP responsive element-binding protein or CREB family transcription factors -
transcription factors involved in the survival of neurons and protecting neurons from 
excitotoxicity- are down-regulated (Crews, Nixon, 2008).  
Fernandez-Lizarbe et al. found that ethanol exposure in mouse microglial cell 
cultures for 24 and 48 hours significantly increased TNF-a, IL-1B, and NO, and that 
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these levels of factors in the medium would initiate apoptosis in cultured cortical cells. 
The researchers also introduced just ethanol -without the microglia released factors- 
directly into the media of cortical cells and did not find a significant increase in apoptosis 
suggesting it was the factors the microglia in the ethanol exposure media released and not 
the ethanol in that media that increased the apoptosis in the cortical cells (Fernandez-
Lizarbe et al., 2009). Boyadjieva and Sarkar in their 2013 study used rat cell cultures of 
microglia and developing hypothalamic cells to test oxidative stress and apoptosis in 
relation to ethanol exposure. They found that hypothalamic cells exposed to ethanol and 
ethanol treated microglia cell culture medium increased the levels of oxidants such as 
reactive oxygen species (ROS) and nitrite, lowered antioxidant levels, and increased 
apoptotic death in the developing hypothalamic cells. However, the presence of ethanol 
treated microglia cell culture medium had more elevated levels of oxidative stress 
response and cell death than the introduction of ethanol alone (Boyadjieva, N., Sarkar, 
K., 2013).   
Though microglial activation does seem to play a significant role in the central 
nervous system’s response to ethanol, its role is more complex than once believed. As 
stated before, neuroinflammation has been linked with microglial activation, but it may 
be a consequence of the neuroinflammation rather than the cause in certain scenarios. 
In Marshall et al.’s paper published in 2013, they used a 4-day binge ethanol 
protocol on rats and saw that there was not a significant increase in pro-inflammatory 
cytokines such as IL-6 and TNF-a between the ethanol and control animals. There was in 
fact a decrease of IL-6 in the entorhinal cortex on day 2 but on no other days. They also 
found that the number of microglia depended on the region of the brain such as the 
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entorhinal cortex or hippocampus. They found no significant change in the amount of 
microglia in the entorhinal cortex but that an increase in microglia persisted in some 
regions of the hippocampus for 28 days. 
 They then decided to measure anti-inflammatory factors in these regions. They 
found that levels of the growth factor, TGF-B, and the anti-inflammatory cytokine, IL-10, 
were significantly increased on the 7th day of abstinence in the hippocampus. There was 
also a lack of disruption of the blood brain barrier which is a classic marker for 
neuroinflammation. These results suggest that the microglia were having a more 
ameliorative effect perhaps preventing neuroinflammation in this 4-day binge protocol 
rather than causing it (Marshall et al., 2013).  
Another aspect of the immune system that has been studied in association with 
ethanol exposure are the toll-like receptors with a special emphasis on Toll like receptor 
4. Toll-like Receptor 4 (TLR4), a receptor associated with the immune system that 
detects bacterial endotoxin, is a gene expressed in microglia. Knocking out this gene has 
been shown to alleviate demyelination in ethanol exposed mice. Alfonso-Loeches et al. 
compared demyelination levels via Western Blot, immunohistochemistry, and mRNA 
expression between wildtype (WT) C57BL/6 female mice and TLR4 knockout (KO) 
C57BL/6 female mice exposed ethanol. As expected, the WT mice exposed to ethanol 
had more demyelination, less myelin associated proteins, and lower levels of myelin-
associated mRNA. The amount of demyelination, myelin associated proteins, and levels 
of myelin-associated mRNA in the TLR4 KO-mice exposed to ethanol was not 
significantly different from the TLR4 KO mice not exposed to ethanol. They also saw 
that the amount of neural degeneration between WT control mice, TLR4 KO control 
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mice, and TLR4 KO ethanol exposed mice were not significantly different while the WT 
ethanol exposed mice had significantly more degenerated neurons with a p<0.01 
(Alfonso-Loeches, Pascual, Gomez-Pinedo, Pascual-Lucas, Renau-Piqueras, Guerri, 
2012). Pascual et al. saw through electron microscopy that myelin sheath damage in 
ethanol exposed TLR-4 intact mice was between 40%-50% in the corpus callosum and 
cerebral cortex and that ethanol exposed TLR-4 KO mice sustained between 4%-8% 
damage (Pascual et al., 2015).  
Alteration in Brain Genetics/Genomics 
Gene expression in the brain tissue of mice is altered depending on the stage of 
addiction, the sex of the animal, and the strain. Koob and Volkow in 2010 have described 
alcoholism as having 3 stages: intoxication, withdrawal, and abstinence/craving (as cited 
by Wilhelm, Hashimoto, Roberts, Sonmez, & Wiren, 2014). Wilhelm’s lab studied gene 
expression and gene networks during these different stages of alcoholism in two 
divergent mouse lines (Withdrawal Seizure Prone [WSP] and Withdrawal Seizure 
Resistant [WSR]) and both sexes. He found that there were substantial differences in 
which types of genes were upregulated and downregulated depending on sex and genetic 
background during the intoxication stage and the peak of ethanol withdrawal. These sex 
differences were then negligible after 21 days of abstinence. At this point in abstinence, 
strain differences were seen. However, both sexes had significant upregulation of 
inflammation/immune function genes (Wilhelm et al., 2014).  
In general, females tend to be more susceptible to damage with less alcohol 
consumption than males (Alfonso-Loeches, Pascual, & Guerri, 2013). Several sources of 
this dimorphism have been identified. Baraonoa et al. in 2001 found that females have 
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less alcohol dehydrogenase in their livers (as cited by Wilhelm et al., 2014) and 
Addolorado et al. in 1999 found that females have different lipid and water ethanol 
partitioning than males (as cited by Wilhelm et al., 2014).  
In Marshall et al.’s study from 2013, it was found that male WSR mice had 
increased expression of Zswim7, a gene associated with damaged DNA repair, during 
withdrawal and abstinence. The most regulated transcripts were found in the females of 
both strains further suggesting that females are more sensitive to the effects of alcohol. 
Though, the most highly regulated genes in females involved sexual differentiation, cell 
death/neurodegeneration, and genes associated with gonadal/breast/prostate diseases. 
Males most highly regulated genes involved transmembrane action/signal peptide 
enrichment, nervous system disorders/development, mitochondria, and 
peroxisome/lysosome functions (Marshall et al., 2013). 
Along with affecting gene expression, ethanol has been studied on its ability to 
cause mutations in the genome. Benassi-Evans and Fenech conducted a study showing 
that ethanol significantly increased aneuploidy in chromosome 17 and other 
chromosomal aberrations such as nuclear budding. Genetic abnormalities in chromosome 
17 are characteristic of breast cancer cells. They studied this phenomena in 2 different 
cell lines. One cell line had a breast cancer background (GM13705) and the other cell line 
had an inactivating mutation in the p53 gene which has also been linked with cancer but 
immortalized the cell line (WIL2-NS) to see if the genetic background affected alcohol’s 
ability to cause genetic abnormalities. They found that GM13705 was more resistant to 
the genomic mutagenic effects of alcohol than WIL2-NS. Nuclear budding, micronuclei 
cells, and nuclear plasma bridges (all markers for genetic abnormalities) were 
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significantly increased in the ethanol treated WIL2-NS cells compared to the control 
WIL2-NS cells starting from the first week of treatment while the GM13705 cell line 
started showing significant changes between experimental and control cells during week 
3. Aneuploidy in chromosome increased significantly from controls in both lines 
(Benassi-Evans, Fenech, 2011). 
Other studies have found evidence that acetaldehyde, a byproduct of metabolizing 
alcohol, may also cause genetic abnormalities. These mutations may also be impacted by 
how much alcohol dehydrogenase, the chemical in our body that breaks down alcohol, is 
produced by the organism’s system which is determined by genetic background (Benassi-
Evans, Fenech, 2011). In fact, Ishiwaka et al.’s study in 2003 showed an association with 
human alcoholics having a genotype that is deficient in alcohol dehydrogenase (as cited 
by Benassi-Evans, Fenech, 2011). 
My Project 
These studies show that more research needs to be put into studying the biological 
differences in AUD cases in order to provide appropriate and effective treatment 
especially in genetically predisposed females who are more susceptible to such damage. 
This background research provides the basis for this exploratory thesis project. 
I chose the mouse model because studies on human alcoholics are limited due to a 
lack of a scientific control. The mouse model is a favorable mammal model in general 
due to its genetic similarity to humans (National Human Genome Research Institute 
[NHGRI], 2012), and its ability to breed quickly allowing researchers to narrow down 
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genes, behaviors, and other factors that may show definitive consequences or 
susceptibilities of alcohol use.  
 Many strains of mice have been tested for ethanol preference, withdrawal 
severity, and other components of alcohol use disorder in behavioral, kinetic, and 
pharmaceutical studies. Female C3H/HeJ mice were chosen for this project due to 
females typically sustaining more brain damage and more severe behavioral issues than 
their male counterparts, and the C3H/HeJ line being more sensitive to ethanol abuse on a 
handling induced convulsions test spectrum (Meeten and Crabbe, 2005). Metten and 
Crabbe in 2005 indexed several popular inbred strains of mice by studying handling 
induced convulsion in the mice after 25 hours of ethanol exposure. 
 The role of microglia in ethanol addiction is being actively explored and therefore 
provides a plethora of new exciting research from which to study and add onto. I studied 
microglial proliferation via Iba-1 antibody staining (a popular stain for detecting and 
quantifying microglial activation). 
 I studied the amount of microglial proliferation immediately after ethanol 
withdrawal and 1 week of abstinence due to the time sensitive nature of microglial 
activation and proliferation.  I also wanted to learn and utilize all the techniques 
associated with this experiment starting from CIE protocol to immunohistochemistry 
staining. I chose the prefrontal cortex area due to its importance in decision making, it’s 
susceptibility to ethanol-associated damage, and the relative ease it is found and accessed. 
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METHODS 
Animals & Apparatus 
 Female C3H/HeJ (C3H) mice (n=16) were obtained from the Jackson 
Laboratories (Bar Harbor, ME) at about 6 weeks of age. Immediately upon arrival, the 
mice were weighed and group-housed in one of four cages in a Plexiglas inhalation 
chamber (60 x 36 x 60 cm). Two cages and therefore two groups of mice were exposed to 
ethanol vapor via a 10-day chronic intermittent ethanol vapor exposure CIE protocol. 
Two other cages and therefore two other groups of mice were exposed to a plain-air 
control. Before being exposed to their respective treatments, the mice were group housed 
in the chambers with plain-air and maintained under a light-dark (LD) 12:12 cycle for 15 
days to allow for acclimation to the cages and environment. This was to avoid the effects 
that the stress and adjustment period of their new housing arrangements could have on 
the results of the study. After this acclimation period, the mice were then put through 
their respective protocols. Each day, the ethanol treated mice were exposed to 16 hours of 
ethanol at the onset of their dark cycle (meaning 12 hours of ethanol exposure in the dark 
phase and 4 hours of ethanol exposure in the light phase) and then 8 hours of plain-air. 
This cycle repeated throughout the duration of the 10-day protocol. 
Chronic Intermittent Ethanol (CIE) Procedure Details 
 The 10-day CIE protocol exposure used in this experiment is based off Dr. Alan 
Rosenwasser’s lab protocol. Along with the ethanol exposure, all animals were 
administered intraperitoneal injections. Ethanol treatment mice were injected with 1.6 
g/kg ethanol and 68.1 mg/kg pyrazole HCl solution. This injection is used to prime the 
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animals for the ethanol exposure. Mice typically metabolize ethanol rapidly, so by 
administering pyrazole HCl, an alcohol dehydrogenase inhibitor, it allows ethanol to 
concentrate in and stabilize the animal’s blood alcohol levels (Logan, McCulley, Seggio, 
and Rosenwasser, 2012). The pyrazole HCl was dissolved in 20% v/v ethanol solution 
and injected at a volume of 20 ml/kg. The control mice were administered an identical 
dose of pyrazole HCl in a 0.9% solution at the same volume ratio to mimic the effects of 
pyrazole in the animal’s system and the stress of being handled and having an injection in 
both groups.  
 Ethanol vapor and air were delivered to the Plexiglas exposure chambers at a rate 
of 10-12 liters per minute to ensure adequate air flow for the animals’ breathing 
requirements. The ethanol chamber was tested via breathalyzer (Lifeloc FC-10; Wheat 
Ridge, CO) to ensure that the mice were also exposed to an adequate amount of ethanol 
to become intoxicated. This was tested by extracting 5.0 ml air samples from the ethanol 
chamber via 60 ml syringe. The 5.0 ml sample was then diluted with 55 ml of plain-air 
and injected steadily into a breathalyzer. 
 At the end of this protocol, the blood ethanol concentrations (BEC) were 
measured. Each mouse was briefly put in a plastic restraining tube where a small blood 
sample (~10 µl) was obtained through the cut made on the tip of the tail made via 
razorblade. The blood was collected directly into a heparinized capillary tube and 
centrifuged for 2 minutes to separate the serum from the plasma. BECs were determined 
from 5 µl plasma samples using an AM-1 alcohol analyzer (Analox Instr., Lunenberg, 
MA). The average blood ethanol concentration was 168.7 mg/dL ± 16.8 mg/dL. 
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Tissue Extraction 
 Half of the animals (1 group of EtOH exposed animals (n=4) and 1 group of air-
only exposed animals (n=4)) were transcardially perfused after their blood was drawn for 
BEC. The other half (1 group of EtOH exposed animals (n=4) and 1 group of air-only 
exposed animals (n=4)) were put into hamster cages (42.5 x 21 x 21.6 cm) out of the 
vapor chambers and were transcardially perfused 7 days later. 
Transcardial Perfusion 
 A 10:1 mg/mL ratio of ketamine:xylazine cocktail at 10 ml/kg bodyweight was 
administered intramuscularly to each animal in the thigh muscle to anaesthetize them 
before the procedure. An extra 0.05mL ketamine/xylazine cocktail was administered to 
each mouse if they still responded to pinching of the toes 15 minutes after the initial dose. 
The mice were held during this process to ensure they stayed warm since they could no 
longer thermoregulate properly.  
 An incision was then made into the chest cavity of the mouse allowing access to 
the heart. I needle was then inserted into the heart. After the needle was clipped in, I 
turned on the automated syringe-pump machine making sure to snip the atrium after 
starting the process. The mouse was perfused with approximately 20mL of PBS and then 
approximately 20mL of 4% PFA. The mouse was then decapitated with bone scissors. 
The brain was then extracted from the skull, put into a labeled cassette, and then 
submerged into 4% PFA solution. The needle of the automated syringe-pump machine 
was then washed with another PBS plunger to clean the tubing from residual 4% PFA. 
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After all the brains were extracted, put into their respective cassettes, and 
submerged in 4% PFA, the container holding the cassettes and 4% PFA were put into a 
4C fridge for approximately 24 hours. The brains were then transferred into a container 
holding 5% sucrose solution for approximately 48 hours. The brains were then 
transferred into a 15% sucrose solution for approximately 48 hours. Then into 30% 
sucrose solution for approximately another 6 days.  
The tissue was then separated into 3 coronal sections with each section frozen 
separately in Optimal Cutting Temperature (OCT) compound inside a labeled cryomold. 
After all the brains were frozen, the cryomolds containing the tissue were put into a -20C 
freezer until they could be put in the cryostat. I made a mistake by not ensuring that the 
tissue stayed cold throughout this process. This was probably the reason there were holes 
in the tissue seen at the microscopic level. Freezing, then thawing, then freezing the 
tissue most likely allowed ice crystals to form and rupture the tissue causing pockets in 
the tissue which can be seen in the Results. The fridge they were being stored in also 
malfunctioned while the tissue was in it which may have compounded with the initial 
rethawing and freezing process. 
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Figure 1. Atlas of the Mouse Brain and Spinal Cord. (Sidman, Angevine, Pierce, 1971). A lateral view 
(left) and ventral view (right) of how the sections were partitioned out. Section A: ~ 0 micron - 220 
microns. Section B: ~ 220 microns – 370 microns. Section C: ~ 370+ microns. 
Tissue Slicing & Staining 
 Section A contained the prefrontal cortex and was therefore the only section that 
was cut and stained. Each section was cut at 10 microns. At least 8 slices were extracted 
from each animal. 2 sections were put onto each slide. The slides were left to incubate at 
37C overnight and then put into -20C until they could be stained. 
Iba-1 Immunohistochemistry Protocol 
 This immunohistochemistry protocol was modified from Dr. Thane Fremouw’s 
Iba-1 immunohistochemistry staining protocol for 40 micron brain tissue and Dr. Kristy 
Townsend’s immunofluorescence for 7-10 micron brain tissue protocol. 
On Day 1, the slides were first washed with 0.05 KPBS for ten minutes to wash 
off the OCT compound. The slides were then transferred to a 1% hydrogen peroxide 
solution diluted in 0.05KPBS for 15 minutes. The slides were then washed 4 times for 5-
minute intervals in 0.05KPBS solution.  
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 A PAP pen was used to circumscribe wells for each tissue section. 100 microliters 
of Iba-1 primary antibody (1:40,000 dilution in 0.05KPBS/0.4% Triton X-100) was put 
into each of these wells and allowed to incubate at room temperature for 1 hour before 
being put into a fridge for 23 hours.  
 The slides were then rinsed with 4 6-minute washes of 0.05 KPBS. The PAP pen 
wells were redrawn if needed. 100 microliters of biotinylated secondary antibody (1:500 
in 0.05M KPBS/ 0.4% Triton X-100) was then put into each well at room temperature for 
1 hour. The slides were then washed with 5 10-minute washes of 0.05 M KPBS. After the 
washes, 100 microliters of A/B solution prepared from an Vectastain Elite Kit (1 drop of 
A, 1 drop of B, and 10mL 0.05 M KPBS/0.4% Triton X-100) were put into each well to 
incubate for 1 hour at room temperature. They were then rinsed with 3 5-minute washes 
in 0.05 M KPBS. The slides were then rinsed with 3 5-minute washes of 0.175 M sodium 
acetate. 100 microliters of NiDAB was then put into each well and allowed to incubate at 
room temperature for 23 minutes. The NiDAB was then extracted via pipette and 100 
microliters of sodium acetate was put into each well to stop the reaction. The slides were 
then put into a 10-minute wash of 0.175 M sodium acetate. After, the slides were rinsed 
with 2 5-minute washes of 0.05 M KPBS. The slides were then allowed to dry over night 
at room temperature. 
Coverslipping Slides 
 The slides were put into an ethanol dilution series starting at 70% for 2 minutes, 
then 95% ethanol for 2 minutes, then 100% ethanol for 2 minutes, and finally into 
another 100% ethanol solution for 2 minutes. After the ethanol dehydration process, the 
slides were put in Histoclear for 5 minutes and then into another container of Histoclear 
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for another 5 minutes. After this, Permount mounting medium was put onto the tissue and 
a coverslip put on top of the solution. Tweezers were used to gently push bubbles out 
from underneath the coverslip. The Permount was then allowed to dry overnight before 
they were viewed underneath a microscope.  
 A second batch of slides went through 3 containers of Histoclear to see if this 
would clear the bubbles found in the first batch.  
Statistics & Analysis 
 The microglia were counted manually and a two-way(treatment*day) ANOVA of 
the average microglia cell count of each animal was calculated through SPSS. I counted 
the microglia from one 650 micron x 430 micron sample from each hemisphere at 
varying depths of the prefrontal medial cortex of each mouse whose tissue was not too 
damaged (example photos Figure 2.C-E). This data can be seen in Table 1. The slides 
were haphazardly blinded by randomly assigning numbers to each slide and covering the 
original label to deter from counting bias.  
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RESULTS 
Blood Ethanol Concentrations & Average Microglia Count 
NIAAA defines binge drinking as a pattern of drinking that brings blood alcohol 
concentration (BAC) levels to 0.08 g/dL. This typically occurs after consuming 4 drinks 
for women and 5 drinks for men in the span of 2 hours. BAC of 0.1 (0.1% or one tenth of 
one percent) means that there are 0.10 g of alcohol for every dL of blood (NIAAA, 
“Drinking Levels Defined”). Included in this table as well is the average microglia cell 
count per 650 micron x 430 micron sample for each animal. 
Mouse (treatment, day after CIE, #) BEC after CIE 
mg/dL 
Average Microglia 
Count 
C01 (ex. Control, Day 0, Mouse #1) NA 6.5 
C02 NA 4.5 
C03 NA 7.5 
C04 NA 6.25 
E01 195.6 5 
E02 165.2 4 
E03 160.8 5.5 
E04 130.4 5 
C75 NA 8.9 
C76 NA 7.25 
C77 NA 10 
C78 NA 9 
E75 (126.1+143.4)/2=13
4.8 
6.416666667 
E76 191.3 5.333333333 
E77 (104.3+117.3)/2=11
0.8 
7.25 
E78 (243.4+278.2)/2=26
0.8 
5.076923077 
Mean ± Standard Error 168.7 ± 16.8 6.5 
Table 1. The blood ethanol concentration of each animal in mg/dL immediately after finishing the CIE 
protocol and microglia cell count. BECs were not taken from controls because they were not exposed to 
ethanol. All ethanol treated mice were above 100 mg/dL meaning they had all achieved a level of 
intoxication comparable to binge drinking as described above. The microglia cell counts are averages of the 
number of cells per 650 micron x 430 micron sample for each animal. 
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Microglial Staining 
The microglia did stain, but the brain tissue had many holes in it making proper 
counting let alone morphological analysis of the microglia very tough. Slides that were 
too damaged (such as A and B below) were not counted. The holes were probably caused 
by improper freezing allowing ice crystals to form in the tissue. 
 
Figure 2: Light microscopy of microglia expressing Iba-1 in several different animals. Images A and B are 
100x photos of the entire medial prefrontal cortex and are examples of how severe the tissue damage was. 
Images C and D are at 400x and display resting and/or low stages of activation. Image E and F show 
thicker ramifications with F being a zoomed in highly ramified microglia. Images C and E also show an 
odd bubbling phenomena in the permount that was only noticeable under a microscope. The white arrows 
point to some iba-1 stained microglia. The cell counts were conducted with photos such as C-E each image 
being 650 microns wide x 430 microns long x 10 microns thick. 
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Figure 3.  Graph and Descriptive Statistics Tables. A Two-Way ANOVA was performed using SPSS, a 
computer program able to perform statistical tests, on 16 female C3H/HeJ mice to examine the effects of 
ethanol exposure and day after withdrawal on mean microglia count in the mPFC. The data used is in the 
third column (Average Microglia Count) of Table 1. A significant main effect was found between Days 
with less microglia being present in the Day 7 animals (p=0.003). Another significant main effect was 
found between Treatments with ethanol animals having more microglia (p=0.002). There was no significant 
interaction between Day and Treatment (p=0.18).	 
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DISCUSSION 
 This pilot study found that time and treatment respectively significantly affected 
the amount of microglia in the medial prefrontal cortex (mPFC). There were more 
microglia present immediately after withdrawal than one week later and the ethanol 
treated mice had more microglia than the control mice. 
Based on previous studies, I expected to see an increase or similar level of 
microglial activation and proliferation in EtOH mice from Day 7 as Day 0 rather than a 
decrease. In McClain et al.’s study, they studied microglia morphology and activation in 
adolescent rats (35 days postnatal) at three time points- 2 days after the last ethanol 
exposure (T2), 7 days after (T7), and 30 days after (T30). They saw that at T2 that there 
were significant morphological changes in microglia in the hippocampus and that there 
were significantly more microglia in the ethanol treated mice. They saw that this pattern 
continued beyond the 2 days and persisted to T30 (McClain, Morris, Deeny, Marshall, 
Hayes, Kiser, Nixon, 2011). Two years later, the same lab studied microglial activation 
again at T7 and T28 but focused on blood brain barrier disruption, cytokines, and 
differences within the different regions of the hippocampus and entorhinal cxortex. They 
found that by T28, the amount of hippocampal microglia in the ethanol treated rats was 
not significantly different from the control rats except in the subregion CA2/3. They also 
found that anti-inflammatory cytokines were being released significantly more than pro-
inflammatory factors in ethanol exposed animals at T7 suggesting that the microglial 
were displaying more of a partially activated M2 phenotype. Partial activation in 
microglia is more closely correlated to neuroprotection rather than neuroinflammation 
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debunking that microglial activation caused by ethanol exposure always equals 
neuroinflammation (Marshall et al., 2013). These studies suggest that there is a temporal 
and regional affect that should be studied more. 
  
 
 
 
 
 
 
 
 
Figure 4. Images from McClain et al.’s “Adolescent binge alcohol exposure induces long-lasting partial 
activation of microglia” at T2 in the hippocampus. Displayed are dozens of microglia with stained for Iba-
1 expression. These pictures are an ideal comparison between the differences in thickness of processes and 
quantity of microglia between control and EtOH treated rodent brain tissue.  
 
The results of my pilot experiment suggest that microglia in female C3H/HeJ 
mice decrease after the 10-day CIE treatment itself in both control and ethanol animals 
with ethanol animals consistently having more microglia than the control animals during 
the two tested time points. This may mean the stress of the 10-day CIE protocol causes an 
increase in microglia for all animals involved with ethanol exacerbating the microglia 
increase and causing this increase to last for at least a week after the CIE protocol. This 
effect by days may also be due to a small n. The decrease in microglia from Day 0 to Day 
7 is more severe in the ethanol treated mice with a difference of 2.7675 microglia while 
the control mice decrease 1.3125 microglia (Figure 3). Previous studies have also found 
that different ethanol dependence protocols have different effects on microglial activation 
in different rodent models. Marshall et al. did a 4-day binge ethanol protocol in rats and 
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got M2 phenotype microglia while other studies have found that chronic intermittent 
ethanol exposure tends to cause a M1 phenotype in microglia in mice (Marshall et al., 
2013). These results may also be due to the brain region. Perhaps microglial activation is 
different in the mPFC as compared to the hippocampus and entorhinal cortex. 
However, this pilot study had few animals per group (n=4 per group) and the 
tissue was damaged. The cells were also an average of cells from different coronal levels 
of the mPFC. Future studies would want to stay consistent with the depth of the tissue 
and separate the subregions of the mPFC (the infralimbic region, prelimbic area, and 
anterior cingulate gyrus) as some other studies have done with the studying the 
subregions of the hippocampus.  
If I were to go further with this experiment, I would have a higher n. I would also 
have another type of control mouse that would not go through any part of the treatment to 
see how much of an impact the stress of the protocol affects the microglial response. I 
would add another time point at about 30 days after last exposure to ethanol to see if 
microglia in the medial prefrontal cortex are still significantly different from the controls. 
This study due to time constraints and damaged tissue could not look at the phenotype of 
the microglia. This can be done through analyzing the ramification of the microglia to see 
if the cells are amoeboid, have bushy processes, or other signs of activation. I would also 
want to look at the cytokines being released at the different timepoints to get a better idea 
of how activated the microglia are and what phenotype they are displaying. I would also 
probably slice the whole brain so that it was easier to track the depth of the brain tissue 
and to study other areas of the brain such as the hippocampus and cerebellum to compare 
them with each other.  
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Another exciting aspect of this project that could be explored is the role of TLR4. 
As discussed in the Introduction, TLR4 plays a crucial role in the immune system’s 
response to ethanol exposure. C3H/HeJ mice have a mutated TLR4 making them more 
resistant to endotoxin (Jackson Labs, n.d.). This aspect of this strain may be partially 
responsible for the results seen in this study. Studies have seen that a knocked out TLR4 
significantly decreases microglia response, neuroinflammation, and demyelination 
(Fernandez-Lizarbe et al., 2009, Alfonso-Loeches et al., 2013, Alfonso-Loeches et al., 
2013). TLR4 KO mice exposed to ethanol also do not show the memory and learning 
deficits associated with ethanol exposure in WT mice (Pascual, Balino, Alfonso-Loeches, 
Aragon, Guerri, 2011). I believe it would be interesting to replace the C3H/HeJ’s mutated 
allele with other versions like the high ethanol preferring C57BL/6 to see if it affects 
microglial response.  
 No matter how this topic is explored further, future studies into alcohol 
dependence and exposure are paramount to finding better treatments for all and 
understanding the effects alcohol has on us.  
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APPENDIX 
AUD- Alcohol Use Disorder 
BAC/BEC- Blood Alcohol Concentration/ Blood Ethanol Concentration 
CIE- Chronic Intermittent Ethanol 
C3H- C3H/HeJ 
DSM 5- Diagnostic and Statistical Manual of Mental Disorders 
DTI- Diffusion Tensor Imaging 
Iba1- Ionized calcium binding adaptor molecule 1 
KO-Knockout 
LD- Light-Dark 
mPFC- medial Prefrontal Cortex 
MRI- Magnetic Resonance Imaging 
NCBI- National Center for Biotechnology 
NF-κB- Nuclear Factor-κB 
NHGRI- National Human Genome Research Institute 
NIAAA- National Institute on Alcohol Abuse and Alcoholism 
OCT- Optimal Cutting Temperature 
T#- Timepoint Day 
TLR4- Toll-like Receptor 4 
WHO- World Health Organization 
WSP- Withdrawal Seizure Prone 
WSR-Withdrawal Seizure Resistant 
WT-Wild Type 
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Ethical Considerations 
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Use Committee (IACUC). University of Maine Animal Welfare Assurance #:  A3754-01. 
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